301 related articles for article (PubMed ID: 11949933)
21. Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.
Lucchiari S; Fogh I; Prelle A; Parini R; Bresolin N; Melis D; Fiori L; Scarlato G; Comi GP
Am J Med Genet; 2002 May; 109(3):183-90. PubMed ID: 11977176
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].
Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F
Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495
[TBL] [Abstract][Full Text] [Related]
23. Compound heterozygous patient with glycogen storage disease type III: identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin.
Okubo M; Horinishi A; Suzuki Y; Murase T; Hayasaka K
Am J Med Genet; 2000 Jul; 93(3):211-4. PubMed ID: 10925384
[TBL] [Abstract][Full Text] [Related]
24. A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect.
Mili A; Ben Charfeddine I; Amara A; Mamaï O; Adala L; Ben Lazreg T; Bouguila J; Saad A; Limem K; Gribaa M
Clin Genet; 2012 Dec; 82(6):534-9. PubMed ID: 22035446
[TBL] [Abstract][Full Text] [Related]
25. DNA-based subtyping of glycogen storage disease type III: mutation and haplotype analysis of the AGL gene in Chinese.
Lam CW; Lee AT; Lam YY; Wong TW; Mak TW; Fung WC; Chan KC; Ho CS; Tong SF
Mol Genet Metab; 2004 Nov; 83(3):271-5. PubMed ID: 15542399
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of the AGL gene: five novel mutations in GSD III patients.
Lucchiari S; Donati MA; Melis D; Filocamo M; Parini R; Bresolin N; Comi GP
Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955720
[TBL] [Abstract][Full Text] [Related]
27. Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients.
Abdullah IS; Teh SH; Khaidizar FD; Ngu LH; Keng WT; Yap S; Mohamed Z
Genes Genomics; 2019 Aug; 41(8):885-893. PubMed ID: 31028654
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.
Endo Y; Fateen E; Aoyama Y; Horinishi A; Ebara T; Murase T; Shin YS; Okubo M
J Hum Genet; 2005; 50(10):538-542. PubMed ID: 16189622
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.
Oh SH; Park HD; Ki CS; Choe YH; Lee SY
Clin Chem Lab Med; 2008; 46(9):1245-9. PubMed ID: 18785866
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III.
Goldstein JL; Austin SL; Boyette K; Kanaly A; Veerapandiyan A; Rehder C; Kishnani PS; Bali DS
Genet Med; 2010 Jul; 12(7):424-30. PubMed ID: 20648714
[TBL] [Abstract][Full Text] [Related]
31. Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III.
Ben Rhouma F; Azzouz H; Petit FM; Khelifa MB; Chehida AB; Nasrallah F; Parisot F; Lasram K; Kefi R; Bouyacoub Y; Romdhane L; Baussan C; Kaabachi N; Ben Dridi MF; Tebib N; Abdelhak S
Mol Biol Rep; 2013 Jul; 40(7):4197-202. PubMed ID: 23649758
[TBL] [Abstract][Full Text] [Related]
32. Molecular and clinical delineation of 12 patients with glycogen storage disease type III in Western Turkey.
Okubo M; Ucar SK; Podskarbi T; Murase T; Shin YS; Coker M
Clin Chim Acta; 2015 Jan; 439():162-7. PubMed ID: 25451950
[TBL] [Abstract][Full Text] [Related]
33. Glycogen storage disease type III in the Irish population.
Crushell E; Treacy EP; Dawe J; Durkie M; Beauchamp NJ
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S215-8. PubMed ID: 20490926
[TBL] [Abstract][Full Text] [Related]
34. Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms.
Bao Y; Yang BZ; Dawson TL; Chen YT
Gene; 1997 Sep; 197(1-2):389-98. PubMed ID: 9332391
[TBL] [Abstract][Full Text] [Related]
35. Bulbar muscle weakness and fatty lingual infiltration in glycogen storage disorder type IIIa.
Horvath JJ; Austin SL; Jones HN; Drake EJ; Case LE; Soher BJ; Bashir MR; Kishnani PS
Mol Genet Metab; 2012 Nov; 107(3):496-500. PubMed ID: 23062577
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of clinical features and AGL gene mutations in a family with glycogen storage disease type IIIa].
Guo L; Lin W; Zhang Z; Zhao X; Zhang S; Cai X; Zhou Q; Song Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Aug; 32(4):502-5. PubMed ID: 26252094
[TBL] [Abstract][Full Text] [Related]
37. Novel variants in Turkish patients with glycogen storage disease.
Çakar NE; Gezdirici A; Topuz HŞ; Önal H
Pediatr Int; 2020 Oct; 62(10):1145-1150. PubMed ID: 32374048
[TBL] [Abstract][Full Text] [Related]
38. High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia.
Cherif W; Ben Rhouma F; Messai H; Mili A; Gribaa M; Kefi R; Ayadi A; Boughamoura L; Chemli J; Saad A; Kaabachi N; Sfar MT; Ben Dridi MF; Tebib N; Abdelhak S
Ann Biol Clin (Paris); 2012; 70(6):648-50. PubMed ID: 23207808
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL.
Lucchiari S; Donati MA; Parini R; Melis D; Gatti R; Bresolin N; Scarlato G; Comi GP
Hum Mutat; 2002 Dec; 20(6):480. PubMed ID: 12442284
[TBL] [Abstract][Full Text] [Related]
40. Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.
Cheng A; Zhang M; Okubo M; Omichi K; Saltiel AR
Hum Mol Genet; 2009 Jun; 18(11):2045-52. PubMed ID: 19299494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
